422 related articles for article (PubMed ID: 26547221)
1. Serum calprotectin--a promising diagnostic marker for adult-onset Still's disease.
Guo Q; Zha X; Li C; Jia Y; Zhu L; Guo J; Su Y
Clin Rheumatol; 2016 Jan; 35(1):73-9. PubMed ID: 26547221
[TBL] [Abstract][Full Text] [Related]
2. Serum calprotectin as a marker for disease activity and severity in adult-onset Still's disease.
Jung SY; Park YB; Ha YJ; Lee KH; Lee SK
J Rheumatol; 2010 May; 37(5):1029-34. PubMed ID: 20231196
[TBL] [Abstract][Full Text] [Related]
3. Serum leucine-rich α2-glycoprotein is a useful biomarker for monitoring disease activity in patients with adult-onset Still's disease.
Ha YJ; Kang EJ; Lee SW; Park YB; Lee SK; Song JS; Choi ST
Scand J Rheumatol; 2015; 44(5):399-403. PubMed ID: 26079682
[TBL] [Abstract][Full Text] [Related]
4. Serum S100A12 may be a useful biomarker of disease activity in adult-onset Still's disease.
Bae CB; Suh CH; An JM; Jung JY; Jeon JY; Nam JY; Kim HA
J Rheumatol; 2014 Dec; 41(12):2403-8. PubMed ID: 25274901
[TBL] [Abstract][Full Text] [Related]
5. Serum S100A8/A9, but not follistatin-like protein 1 and interleukin 18, may be a useful biomarker of disease activity in adult-onset Still's disease.
Kim HA; An JM; Nam JY; Jeon JY; Suh CH
J Rheumatol; 2012 Jul; 39(7):1399-406. PubMed ID: 22660800
[TBL] [Abstract][Full Text] [Related]
6. Beneficial use of serum ferritin and heme oxygenase-1 as biomarkers in adult-onset Still's disease: A multicenter retrospective study.
Kirino Y; Kawaguchi Y; Tada Y; Tsukamoto H; Ota T; Iwamoto M; Takahashi H; Nagasawa K; Takei S; Horiuchi T; Ichida H; Minota S; Ueda A; Ohta A; Ishigatsubo Y
Mod Rheumatol; 2018 Sep; 28(5):858-864. PubMed ID: 29278009
[TBL] [Abstract][Full Text] [Related]
7. The potential role of advanced glycation end products (AGEs) and soluble receptors for AGEs (sRAGE) in the pathogenesis of adult-onset still's disease.
Chen DY; Chen YM; Lin CC; Hsieh CW; Wu YC; Hung WT; Chen HH; Lan JL
BMC Musculoskelet Disord; 2015 May; 16():111. PubMed ID: 25956266
[TBL] [Abstract][Full Text] [Related]
8. Serum Heparin-Binding Protein as a Potential Biomarker to Distinguish Adult-Onset Still's Disease From Sepsis.
Tian R; Chen X; Yang C; Teng J; Qu H; Liu HL
Front Immunol; 2021; 12():654811. PubMed ID: 33868298
[TBL] [Abstract][Full Text] [Related]
9. New Markers for Adult-Onset Still's Disease.
Mitrovic S; Fautrel B
Joint Bone Spine; 2018 May; 85(3):285-293. PubMed ID: 28529117
[TBL] [Abstract][Full Text] [Related]
10. Significant association of past parvovirus B19 infection with cytopenia in both adult-onset Still's disease and systemic lupus erythematosus patients.
Chen DY; Chen YM; Lan JL; Tzang BS; Lin CC; Hsu TC
Clin Chim Acta; 2012 May; 413(9-10):855-60. PubMed ID: 22309679
[TBL] [Abstract][Full Text] [Related]
11. Clinical features and hyperferritinemia diagnostic cutoff points for AOSD based on ROC curve: a Chinese experience.
Lian F; Wang Y; Yang X; Xu H; Liang L
Rheumatol Int; 2012 Jan; 32(1):189-92. PubMed ID: 20798946
[TBL] [Abstract][Full Text] [Related]
12. Plasma microRNA Profiles as a Potential Biomarker in Differentiating Adult-Onset Still's Disease From Sepsis.
Hu Q; Gong W; Gu J; Geng G; Li T; Tian R; Yang Z; Zhang H; Shao L; Liu T; Wan L; Jia J; Yang C; Shi Y; Shi H
Front Immunol; 2018; 9():3099. PubMed ID: 30687316
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of Interleukin-18 as a Diagnostic Biomarker to Differentiate Adult-Onset Still's Disease With/Without Macrophage Activation Syndrome From Other Secondary Hemophagocytic Lymphohistiocytosis in Adults.
Shiga T; Nozaki Y; Tomita D; Kishimoto K; Hirooka Y; Kinoshita K; Funauchi M; Matsumura I
Front Immunol; 2021; 12():750114. PubMed ID: 34691064
[TBL] [Abstract][Full Text] [Related]
14. Association of intercellular adhesion molecule-1 with clinical manifestations and interleukin-18 in patients with active, untreated adult-onset Still's disease.
Chen DY; Lan JL; Lin FJ; Hsieh TY
Arthritis Rheum; 2005 Jun; 53(3):320-7. PubMed ID: 15934126
[TBL] [Abstract][Full Text] [Related]
15. Adult-onset Still's disease: still a diagnosis of exclusion. A nested case-control study in patients with fever of unknown origin.
Vanderschueren S; Hermans F; De Munter P; Knockaert D
Clin Exp Rheumatol; 2012; 30(4):514-9. PubMed ID: 22510428
[TBL] [Abstract][Full Text] [Related]
16. [Clinical characteristics and diagnostic indicators of macrophage activation syndrome in patients with systemic lupus erythematosus and adult-onset Still's disease].
Yao HH; Yang F; Tang SM; Zhang X; He J; Jia Y
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Dec; 55(6):966-974. PubMed ID: 38101776
[TBL] [Abstract][Full Text] [Related]
17. Clinical manifestations but not cytokine profiles differentiate adult-onset Still's disease and sepsis.
Rau M; Schiller M; Krienke S; Heyder P; Lorenz H; Blank N
J Rheumatol; 2010 Nov; 37(11):2369-76. PubMed ID: 20810496
[TBL] [Abstract][Full Text] [Related]
18. Extremely High Serum Ferritin: An Instrumental Marker of Masquerading Adult-Onset Still's Disease with Hemophagocytic Syndrome.
Yamashita S; Furukawa NE; Matsunaga T; Hirakawa Y; Tago M; Yamashita SI
Am J Case Rep; 2017 Dec; 18():1296-1301. PubMed ID: 29208852
[TBL] [Abstract][Full Text] [Related]
19. Serum Levels of Interleukin 33 and Soluble ST2 Are Associated with the Extent of Disease Activity and Cutaneous Manifestations in Patients with Active Adult-onset Still's Disease.
Han JH; Suh CH; Jung JY; Ahn MH; Kwon JE; Yim H; Kim HA
J Rheumatol; 2017 Jun; 44(6):740-747. PubMed ID: 28365573
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-18 as an efficient marker for remission and follow-up in patients with inactive adult-onset Still's disease.
Jung KH; Kim JJ; Lee JS; Park W; Kim TH; Jun JB; Yoo DH
Scand J Rheumatol; 2014; 43(2):162-9. PubMed ID: 24134323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
